Chargement en cours...
Unintended Effects of Orphan Product Designation for Rare Neurological Diseases
Since the introduction of the Orphan Drug Act in 1983, designed to promote development of treatments for rare diseases, at least 378 orphan drugs have been approved. Incentives include financial support, tax credits and, perhaps most importantly, extended market exclusivity. These incentives have en...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490440/ https://ncbi.nlm.nih.gov/pubmed/23109143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23672 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|